{"id":"https://openalex.org/W4414799571","doi":"https://doi.org/10.1093/neuonc/noaf193.158","title":"P02.31.B INDUCTION OF A CHRONIC INTERFERON STIMULATED TUMOR-ASSOCIATED MYELOID CELL PHENOTYPE IS DIRECTLY ORCHESTRATED BY ABERRANT TUMOR-INTRINSIC EGFR-ACTIVATION IN GLIOBLASTOMA","display_name":"P02.31.B INDUCTION OF A CHRONIC INTERFERON STIMULATED TUMOR-ASSOCIATED MYELOID CELL PHENOTYPE IS DIRECTLY ORCHESTRATED BY ABERRANT TUMOR-INTRINSIC EGFR-ACTIVATION IN GLIOBLASTOMA","publication_year":2025,"publication_date":"2025-10-01","ids":{"openalex":"https://openalex.org/W4414799571","doi":"https://doi.org/10.1093/neuonc/noaf193.158"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noaf193.158","doi":"https://doi.org/10.1093/neuonc/noaf193.158","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noaf193.158","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/27/Supplement_3/iii49/64482671/noaf193.158.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/27/Supplement_3/iii49/64482671/noaf193.158.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025446338","display_name":"Marissa S. Pioso","orcid":"https://orcid.org/0000-0002-2938-6678","observed_orcids":["https://orcid.org/0000-0002-2938-6678"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M S Pioso","raw_affiliation_strings":["UCLA , Los Angeles, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA , Los Angeles, CA,","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100351543","display_name":"Ming Li","orcid":"https://orcid.org/0009-0002-9307-7009","observed_orcids":["https://orcid.org/0009-0002-9307-7009"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Li","raw_affiliation_strings":["UCLA , Los Angeles, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA , Los Angeles, CA,","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048850369","display_name":"Katie B. Grausam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K B Grausam","raw_affiliation_strings":["Cedars-Sinai Medical Center , Los Angeles, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center , Los Angeles, CA,","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018100920","display_name":"Joshua J. Breunig","orcid":"https://orcid.org/0000-0002-3735-3390","observed_orcids":["https://orcid.org/0000-0002-3735-3390"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Breunig","raw_affiliation_strings":["Cedars-Sinai Medical Center , Los Angeles, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center , Los Angeles, CA,","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D A Nathanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D A Nathanson","raw_affiliation_strings":["UCLA , Los Angeles, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA , Los Angeles, CA,","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010449744","display_name":"Robert Michael Prins","orcid":"https://orcid.org/0000-0002-6282-6583","observed_orcids":["https://orcid.org/0000-0002-6282-6583"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R M Prins","raw_affiliation_strings":["UCLA , Los Angeles, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA , Los Angeles, CA,","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"Supplement_3","first_page":"iii49","last_page":"iii49"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.6514000296592712,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.6514000296592712,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.3158999979496002,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/egfr-activation","display_name":"EGFR activation","score":0.8980000019073486},{"id":"https://openalex.org/keywords/tumor-associated-myeloid-cells","display_name":"tumor-associated myeloid cells","score":0.9259999990463257},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.7910000085830688},{"id":"https://openalex.org/keywords/interferon-stimulated-genes","display_name":"interferon-stimulated genes","score":0.972000002861023},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.7170000076293945},{"id":"https://openalex.org/keywords/microglia","display_name":"microglia","score":0.6439999938011169},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.8790000081062317},{"id":"https://openalex.org/keywords/mcp-1","display_name":"MCP-1","score":0.8069999814033508},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.6610000133514404},{"id":"https://openalex.org/keywords/egfrviii","display_name":"EGFRvIII","score":0.6980000138282776},{"id":"https://openalex.org/keywords/tumor-conditioned-medium","display_name":"tumor-conditioned medium","score":0.4740000069141388},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.4569999873638153}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6937999725341797},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5719000101089478},{"id":"https://openalex.org/C101666144","wikidata":"https://www.wikidata.org/wiki/Q2587862","display_name":"CCL2","level":4,"score":0.5429999828338623},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.5401999950408936},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.5332000255584717},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.482699990272522},{"id":"https://openalex.org/C5858377","wikidata":"https://www.wikidata.org/wiki/Q986112","display_name":"CXCL10","level":4,"score":0.47290000319480896},{"id":"https://openalex.org/C2779830541","wikidata":"https://www.wikidata.org/wiki/Q1622829","display_name":"Microglia","level":3,"score":0.4681999981403351},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.461899995803833},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.43230000138282776},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.40639999508857727},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.39469999074935913},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.3763999938964844},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.37380000948905945},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.34610000252723694},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.34139999747276306},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34060001373291016},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3384000062942505},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.3359000086784363},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.32839998602867126},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.321399986743927},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.31839999556541443},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.3165000081062317},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.29989999532699585},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.2939999997615814},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.27410000562667847},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.26660001277923584},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.26649999618530273},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.2605000138282776},{"id":"https://openalex.org/C2778170410","wikidata":"https://www.wikidata.org/wiki/Q506253","display_name":"Dendritic cell","level":3,"score":0.25940001010894775},{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.2590999901294708},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.25699999928474426},{"id":"https://openalex.org/C17502307","wikidata":"https://www.wikidata.org/wiki/Q411999","display_name":"CXCL9","level":5,"score":0.25600001215934753},{"id":"https://openalex.org/C2779130545","wikidata":"https://www.wikidata.org/wiki/Q233309","display_name":"Brain tumor","level":2,"score":0.2558000087738037},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.25200000405311584},{"id":"https://openalex.org/C55721878","wikidata":"https://www.wikidata.org/wiki/Q15220362","display_name":"Myeloid-derived Suppressor Cell","level":4,"score":0.25119999051094055}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noaf193.158","doi":"https://doi.org/10.1093/neuonc/noaf193.158","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noaf193.158","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/27/Supplement_3/iii49/64482671/noaf193.158.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12493337","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12493337/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noaf193.158","doi":"https://doi.org/10.1093/neuonc/noaf193.158","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noaf193.158","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/27/Supplement_3/iii49/64482671/noaf193.158.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G1005326806","display_name":null,"funder_award_id":"LX22NPO5102","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"}],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4414799571.pdf","grobid_xml":"https://content.openalex.org/works/W4414799571.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND":[1],"Glioblastoma":[2],"(GB)":[3],"is":[4,81,177,217,253,276,295],"a":[5,49,56,72,100,338,375,390],"lethal":[6],"primary":[7],"brain":[8],"tumor":[9,32,42,58,126,189,206,237,272],"frequently":[10],"driven":[11],"by":[12,115,278,379],"amplification":[13],"and":[14,36,47,79,124,132,150,198,230,261,314,357,360],"aberrant":[15],"activation":[16,70,176,216,294,351],"of":[17,31,169,187,194,212,245,308,337,364],"the":[18,29,89,242,256,282,330,335,370],"epidermal":[19],"growth":[20,43],"factor":[21],"receptor":[22],"(EGFR).":[23],"Tumor-associated":[24],"myeloid":[25,183,195],"cells":[26],"(TAMs)":[27],"comprise":[28],"majority":[30],"infiltrating":[33],"leukocytes":[34],"(TILs)":[35],"secrete":[37],"inflammatory":[38],"molecules":[39],"that":[40,332],"promote":[41],"including":[44,311],"IL-6,":[45],"IL-1\u03b2,":[46],"EGF,":[48],"canonical":[50],"EGFR":[51,69,159,175,215,293,321,333,350],"ligand.":[52],"These":[53],"TAMs":[54,319],"orchestrate":[55],"suppressive":[57],"immune":[59],"microenvironment":[60],"(TIME)":[61],"with":[62,108,157,179,220,297],"poor":[63],"T":[64],"cell":[65,184],"infiltration.":[66,185],"However,":[67],"whether":[68],"plays":[71],"direct":[73],"role":[74],"in":[75,200,205,226,247,271,281,301,318,343,374],"mediating":[76],"TAM":[77,258,298,340,353,376],"recruitment":[78,354],"phenotype":[80,377],"poorly":[82],"understood.":[83],"MATERIAL":[84],"AND":[85],"METHODS":[86],"We":[87],"leveraged":[88],"MADR-mEGFRvIII":[90,149,172,188],"murine":[91],"GB":[92,154],"model":[93],"which":[94,202],"expresses":[95],"constitutively":[96],"active":[97],"mEGFRvIII":[98],"under":[99],"tetracycline-off":[101],"promoter.":[102],"Orthotopic":[103],"MADR-mEGFRvIII-bearing":[104],"mice":[105],"were":[106,128,139,288],"treated":[107],"doxycycline":[109],"(dox)":[110],"for":[111,255],"one":[112],"week":[113],"followed":[114],"flow":[116],"cytometric":[117],"TIME":[118],"profiling.":[119],"Tumor":[120],"conditioned":[121],"media":[122],"(CM)":[123],"orthotopic":[125],"lysates":[127,207],"assessed":[129,289],"via":[130,141,355],"ELISA":[131],"cytokine":[133],"array.":[134],"Lymphocytes":[135],"(CD4,":[136],"CD8,":[137],"NK)":[138],"depleted":[140],"antibody":[142],"administration.":[143],"Magnetically":[144],"isolated":[145],"CD45+":[146],"TILs":[147,170,213,287],"from":[148,171,208,320,397],"newly":[151],"diagnosed":[152],"(nd)":[153],"patient":[155,286],"tumors":[156,173,323],"known":[158],"status":[160],"underwent":[161],"bulk":[162],"or":[163],"single-cell":[164],"RNA":[165],"sequencing.":[166],"RESULTS":[167],"Immunophenotyping":[168],"revealed":[174,214],"associated":[178,219,296],"significantly":[180,218],"enhanced":[181],"F4/80+":[182],"Assessment":[186],"CM":[190],"identified":[191],"EGFR-dependent":[192],"secretion":[193,359],"chemoattractants":[196],"CCL2":[197,356],"CXCL10":[199,358],"vitro,":[201],"was":[203,268,316],"corroborated":[204],"mice.":[209],"Further,":[210],"sequencing":[211],"interferon":[221],"(IFN)-stimulated":[222],"gene":[223],"(ISG)":[224],"expression":[225,300,307],"both":[227],"brain-resident":[228],"microglia":[229],"monocytic":[231],"macrophages.":[232],"Lymphocyte":[233],"depletion":[234],"prior":[235],"to":[236,290,325,393],"implantation":[238],"did":[239],"not":[240,269],"affect":[241],"EGFR-driven":[243,385],"induction":[244,336,363],"ISGs":[246,310],"TILs,":[248],"suggesting":[249],"type":[250,265,327,365],"I":[251,266,366],"IFN":[252,267,275,341,367,399],"responsible":[254],"observed":[257,317],"phenotype.":[259],"Pan-IFN\u03b1":[260],"IFN\u03b2":[262],"ELISAs":[263],"confirmed":[264],"present":[270],"CM,":[273],"indicating":[274],"secreted":[277],"other":[279],"constituents":[280],"TIME.":[283],"Importantly,":[284],"ndGB":[285],"determine":[291],"if":[292],"ISG":[299,380],"human":[302],"GB.":[303,344],"Indeed,":[304],"significant":[305],"differential":[306],"numerous":[309],"IRF7,":[312],"IFI44,":[313],"MX1":[315],"activated":[322],"compared":[324],"wild":[326],"further":[328],"supporting":[329],"concept":[331],"orchestrates":[334],"chronic":[339,398],"response":[342],"CONCLUSION":[345],"Our":[346],"results":[347],"indicate":[348],"tumor-intrinsic":[349],"promotes":[352],"potentiates":[361],"robust":[362],"signaling":[368],"within":[369],"TIME,":[371],"ultimately":[372],"resulting":[373],"characterized":[378],"expression.":[381],"Therapeutically":[382],"targeting":[383],"this":[384],"tumor-TAM":[386],"crosstalk":[387],"may":[388],"be":[389],"viable":[391],"strategy":[392],"reduce":[394],"immunosuppression":[395],"arising":[396],"signaling.":[400]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}